AD as clinical syndrome not disease

Ad As Clinical Syndrome Not Disease enters the Adult Cognitive Disease corpus through the work of Rafael Rodríguez-Puertas (submission 94), and is indexed here as one of the concepts that submission puts to work.

The argument it belongs to

Rafael Rodríguez-Puertas's submission is summarised in this corpus as:

AD is a clinical syndrome of irreversible dementia initiated by cholinergic impairment of the basalocortico-hippocampal pathway, leading to axonal transport failure or 'axonal atheroma.' Multiple causes can damage the seven processes required for memory building, and environmental toxins like DDT contribute to cholinergic neurotransmission disruption and the ACA triad (Atherosclerosis-Cancer-AD).

Where it sits

The submission scores against the framework's convergence nodes as: cytoskeletal collapse 6 · ApoE4 hub 3 · endosomal nexus 2 · compensatory paradigm 2 · neuroimmune interface 2 · transcriptional / epigenetic 1.

Its declared subject matter: axonal-transport, cholinergic-pathway, environmental-toxins, lipid-metabolism, memory-building, clinical-syndrome, DDT, ACA-triad.

Named by the same submission

3 other concepts enter the corpus through the same paper, so they cover adjacent ground: Axonal atheroma hypothesis · Environmental toxin contribution · Memory building framework.

Assembled from the corpus rather than written: the summary is quoted from the submission that named it; the node scores are read from its dossier. It has not yet been expanded into an article.